BARCLAYS PLC

Position in STTK — Shattuck Labs, Inc.

CIK 312069 LONDON, X0

Position in STTK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$770,821

+$769,147 QoQ

Shares Held

119,879

+5570.7% QoQ

Ownership

0.156%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,393,117,077 across 362 Biotechnology names. STTK ranks #108 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	INCY	Incyte Corp	367,095	$34,550,980

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$770,821	119,879	+5570.7%	Shares	Defined	2026-05-15
2025-06-30	$1,674	2,114	-95.8%	Shares	Sole	2026-02-27
2025-03-31	$48,340	50,885	-16.6%	Shares	Sole	2026-03-17
2024-12-31	$73,798	60,991	+12.3%	Shares	Sole	2026-03-19
2024-09-30	$189,545	54,311	+299.5%	Shares	Sole	2026-03-31
2024-06-30	$52,472	13,594	+6980.2%	Shares	Sole	2026-03-23
2024-03-31	$1,716	192	-98.8%	Shares	Sole	2026-03-24
2023-09-30	$25,035	16,471	0.0%	Shares	Sole	2026-03-26
2023-06-30	$51,389	16,471	0.0%	Shares	Sole	2026-03-27
2023-03-31	$48,424	16,471	0.0%	Shares	Sole	2026-03-30
2022-12-31	$37,883	16,471	0.0%	Shares	Sole	2026-03-30
2022-09-30	$44,471	16,471	-0.2%	Shares	Sole	2022-11-03
2022-06-30	$67,030	16,510	-20.9%	Shares	Sole	2022-08-12
2022-03-31	$88,863	20,860	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.